Older adults in the United States are disproportionately affected by health care costs compared with their counterparts in ...

A new study revealed divergent policies on artificial intelligence (AI) use in peer review among leading medical journals, ...

With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

While race-aware models showed superior statistical calibration across racial and ethnic groups, their benefits in clinical ...

Recent insights shed light onto the most effective diagnostic tools for laryngeal myasthenia gravis (MG), a poorly understood ...

Women who had children had a higher risk of reaching a visual acuity below 6/24 compared with those who did not have children ...

Gene therapies can be life-changing for people, but the high cost plus the burden of treatment remain barriers to access and ...

Presentations at the 2024 Asembia Specialty Pharmacy Summit focused on reshaping specialty pharmacy while keeping patients ...

Chapa, MD, discusses key findings, limitations, and future research directions from his study on racial disparities in idiopathic pulmonary fibrosis (IPF) outcomes.

Experts are now urging the inclusion of sickle cell disease in the global health agenda to address disparities in treatment access. From 2000 to 2021, global births of babies with SCD rose by 13.7%, ...

The 6-year mandatory Increasing Organ Transplant Access Model aims to boost kidney transplants and address disparities by ...

The median launch prices in the US increased from $29,630 (IQR, $1322-$49,691) for drugs approved in 201 to $84,240 (IQR, ...